Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/03/25
End: 05/31/27
Due: 05/31/28
Phase: N/A
Priority: Normal
Start: 06/29/22
End: 09/30/24
Due: 09/30/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Evaluation of the Impact of the EDIT-B® Blood Test on the Health Status of Patients Presenting a Major Depressive Episode. Clinical Utility and Medico-Economic Aspects | NCT06507787 | Alcediag | user2@example.com | None | 2025-02-03 | 2027-05-31 | 2028-05-31 | - | - | 2025-07-14 |
| Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers | NCT05603819 | Alcediag | user2@example.com | None | 2022-06-29 | 2024-09-30 | 2025-09-30 | - | - | 2025-07-14 |